DKSH Business Unit Technology has initiated “UniTEC Connect,” a platform to provide students and researchers with insights ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pacific Biosciences of California, Inc. has a 52-week low of $1.16 and a 52-week high of $5.01. The company has a market cap of $366.98 million, a price-to-earnings ratio of -0.82 and a beta of 1.92.

Welcome to the Department of Biosciences. The department delivers innovative, TEF Gold standard teaching and research in subjects including biomedical science, microbiology, biochemistry, pharmacology ...

Pacific Biosciences' Q4'24 results were another disappointment, with revenue and margin misses, and 2025 guidance was notably below expectations. Underlying utilization growth (genetic data ...

Pacific Biosciences of California has a 12-month low of $1.16 and a 12-month high of $6.09. The company has a quick ratio of 8.64, a current ratio of 9.74 and a debt-to-equity ratio of 1.97.

MANILA, Philippines — The leaders of the Philippines and Palau on Monday reaffirmed their bilateral ties, emphasizing maritime cooperation, economic collaboration, and labor partnerships between ...